“⌚슈어맨 【위너보증.com / 가입코드 9122】 토토사이트 ⌚”的搜索结果，显示 311-320 项，共有 9368 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the safety profile of SX-682 alone and in combination with pembrolizumab in subjects with metastatic ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

4. 皮肤过敏原试验 - 妙佑医疗国际

   考虑是否进行皮肤过敏试验？了解皮肤过敏试验的风险、检测结果和一般过程。

5. 妇产科- 临床试验- 妙佑医疗国际

   The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy and ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...